We use cookies. EPF Congress uses cookies to make sure you get the best experience on our website.

The congress' contributors

The congress' Contributors

Dimitrios Athanasiou

Dimitrios Athanasiou holds a BA in Business Administration and an MBA in Financial Management. He speaks three European languages and has more than 25 years’ experience with international business projects, working in various countries in consulting, developing and reorganizing companies.

Having a passionate personality and technocratic background, he educated himself with basic rare disease and advocacy knowledge via the EURORDIS Summer School and then with the 14 month Patient Expert Course of the European Patient Academy of Therapeutic Innovation (EUPATI) acquiring basic biotech and regulatory knowledge, where he served as a Member of EUPATI’s Course Committee for the next year, representing the patient voice. Being a EUPATI fellow, he established the Greek EUPATI National Liaison Team. Locally in Greece he is the patient representative of MDA HELLAS, created an active network of patient advocates, and became a board member of the World Duchenne Organization (WDO) promoting a vibrant network of patient organizations where children with DMD will have access to the best care irrelevant to where they live.

As a strong and committed patient advocate for DMD and rare diseases, he serves the patient community through various roles. He is a board member of EPF, a EURORDIS EPAC/TAG member, he served in the Board of the European Forum for Good Clinical Practice (EFGCP), Co-Chairing the Children Medicines Working Party (CMWP), Patient Advisor in TREAT-NMD Advisory Committee for Therapeutics (TACT), DIA’s Program Committee Member and many others.

In 2014 he was nominated patient expert by EMA for DMD and has participated in several of EMA's Scientific Advice, SAG, Protocol Assistance and CHMP pilot meetings for Duchenne, providing the essential patient representative perspective when companies request regulatory advice or approval. He currently serves as PDCO member in European Medicines Agency representing EURORDIS since 2017

Master of Ceremonies

Speakers

Learn more about Ana Toledo-Chávarri

Ana Toledo-Chávarri

Coordinator of the Patient Involvement Strategy, Spanish Network of Agencies for Assessing National Health System Technologies and Performance- RedETS

Ana Toledo-Chávarri

Advisory Board Members

Programme Committee Members

Patients included

We are proud to announce that EPF Congress 2021 is Patients Included™. This means that EPF is committed to incorporating the experience of patients as experts in living with their condition while ensuring they were neither excluded nor exploited.

More information